Globus Medical INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.22% of Globus Medical Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has reported a 0% beneficial ownership in Globus Medical Inc. common stock following an internal realignment.
NYSE
SCHEDULE 13G/A: Janus Henderson Group PLC Discloses 6.1% Stake in Globus Medical, Inc. via Amended SEC Filing
Janus Henderson Group PLC has filed an Amendment No. 7 to its Schedule 13G, disclosing a beneficial ownership of 6.1% of Globus Medical, Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 9.1% of Globus Medical Inc.'s Class A Stock as of March 31, 2025.
NYSE
Janus Henderson Group PLC has filed an amended Schedule 13G, reporting a 5.8% passive ownership stake in Globus Medical, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Significant 7.8% Stake in Globus Medical Inc. Class A Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.8% of Globus Medical Inc.'s Class A Common Stock as of December 31, 2024.